ENANTA PHARMACEUTICALS INC — Director's Dealing 2021

Dec 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENANTA PHARMACEUTICALS INC (ENTA)
CIK: 0001177648
Period of Report: 2021-12-01

Reporting Person: Gardiner Nathaniel S. (Sr. VP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-01	Common Stock	F	557	$87.68	Disposed	59226	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5910	Indirect

Footnotes

F1: Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 20, 2020.

F2: These shares are held by a grantor retained annuity trust created by the reporting person for the benefit of himself and his two adult children.